Citation

Mackman RL, Mish M, Chin G, Perry JK, Appleby T, Aktoudianakis V, Metobo S, Pyun P, Niu C, Daffis S, Yu H, Zheng J, Villasenor AG, Zablocki J, Chamberlain J, Jin H, Lee G, Suekawa-Pirrone K, Santos R, Delaney WE, Fletcher SP.: Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B. J Med Chem, Volume 63 (18), 2020

Authors

Aktoudianakis V, Appleby T, Chamberlain J, Chin G, Daffis S, Delaney WE, Fletcher SP., Jin H, Lee G, Mackman RL, Metobo S, Mish M, Niu C, Perry JK, Pyun P, Santos R, Suekawa-Pirrone K, Villasenor AG, Yu H, Zablocki J, Zheng J

Journal

J Med Chem

Year

2020

DOI

10.1021/acs.jmedchem.0c00100

PubMed

32407112

Machine-readable

REST APIRDF